Results 251 to 260 of about 585,431 (288)

Ellagic Acid and Its Nanoparticles Mitigate Atherosclerosis by Elevating Low-Density Lipoprotein Receptor Levels Through Targeting of the Epidermal Growth Factor Receptor. [PDF]

FASEB Bioadv
Li GT, Wang LT, Yin HL, Zhao SQ, Sheng J, Huang YW, Wang XJ.   +6 more
europepmc   +1 more source

Optimizing oral low-density lipoprotein cholesterol-lowering therapy in statin-intolerant patients: A simulation study in France

Francois Schiele, Michel Farnier, Bénédicte Borsik   +2 more
openalex   +1 more source

Effect of xylitol on low‑density lipoprotein‑stimulated oxidative stress in THP‑1 cells. [PDF]

Mol Med Rep
Huang Z, Li A, Huang R, Shi M, Yang R, Wang W, Huang Z, Liu Y, Wu J.   +8 more
europepmc   +1 more source

High-frequency ultrasound induced the preparation of oxidized low density lipoprotein. [PDF]

Ultrason Sonochem
Li Y, Yang W, Zhang X, Ba J, Yang H, Wang W, Zhang K, Yang Z, Liang H, Li Z, Ashokkumar M, Zhang J, Gao Z, Yu Y.   +13 more
europepmc   +1 more source

Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction

, 2016
Henry Ca, Lyon Ra, Hua Ling
openalex   +1 more source

Correction for Jang et al., Lipid raft proteomics identify endothelial myosin-9 (MYH9) as a regulator of low-density lipoprotein transcytosis and atherosclerosis. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

Low-Density Lipoprotein Cholesterol Levels and Bleeding Risk in Venous Thromboembolism.

JAMA Netw Open
Siniscalchi C, Meschi T, Di Micco P, Imbalzano E, Hernández-Blasco L, Mahé I, Fernández-Reyes JL, García-Ortega A, Verhamme P, Alfonso-Megido J, Monreal M, RIETE Investigators.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Electronegative low-density lipoprotein

Current Opinion in Lipidology, 2004
The occurrence in blood of an electronegatively charged LDL was described in 1988. During the 1990s reports studying electronegative LDL (LDL(-)) were scant and its atherogenic role controversial. Nevertheless, recent reports have provided new evidence on a putative atherogenic role of LDL(-).
José Luis, Sánchez-Quesada, Sonia, Benítez, Jordi, Ordóñez-Llanos   +2 more
openaire   +2 more sources

Low-density lipoprotein heterogeneity

Baillière's Clinical Endocrinology and Metabolism, 1995
As a key feature of the ALP, a raised level of small, dense LDL forms part of what is potentially the most common collection of lipoprotein abnormalities to influence the risk of CHD in the general population. The consistency of the association between a prevalence of small, dense LDL and increased risk of CHD is impressive, though the practical ...
openaire   +2 more sources

Circulating low density lipoprotein (LDL)

Hormone Molecular Biology and Clinical Investigation, 2018
Abstract Low-density lipoprotein (LDL) particles are known as atherogenic agents in coronary artery diseases. They modify to other electronegative forms and may be the subject for improvement of inflammatory events in vessel subendothelial spaces. The circulating LDL value is associated with the plasma PCSK-9 level. They internalize into
Mohsen, Khosravi, Reza, Hosseini-Fard, Mohammad, Najafi   +2 more
openaire   +2 more sources